Insider Trading activities of Bridgebio Pharma, Inc. (BBIO)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bridgebio Pharma, Inc. (BBIO) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bridgebio Pharma, Inc. since year 2005. Table 2 shows the detailed insider transactions of Bridgebio Pharma, Inc. since 2005. The reporting company's ticker symbol is BBIO. The reporting company's CIK number is 1743881.
The total value of stock buying since 2005 is $286,302,100.
The total value of stock sales since 2005 is $9,140,220.
The total value of stock option exercises since 2005 is $340,000.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Bridgebio Pharma, Inc. (BBIO).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2020-01 0 $0 157,582 $5,232,573 20,000 $340,000
2019-12 0 $0 100,000 $3,907,647 0 $0
2019-07 2,723,600 $46,301,200 0 $0 12,338,050 $0
2019-06 14,117,700 $240,000,900 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Bridgebio Pharma, Inc. insiders (BBIO)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2020-01-14 Homcy Charles J (Chairman of Pharmaceuticals) Sale 10,000 35.00 350,000
2020-01-14 Homcy Charles J (Chairman of Pharmaceuticals) Option Ex 10,000 17.00 170,000
2020-01-08 Turtle Cameron (See Remarks) Sale 12,807 34.44 441,073
2020-01-08 Turtle Cameron (See Remarks) Option Ex 10,000 17.00 170,000
2020-01-03 Stephenson Brian C (See Remarks) Sale 3,636 32.12 116,806
2020-01-03 Henderson Michael Thomas (See Remarks) Sale 358 32.64 11,685
2020-01-03 Kumar Neil (See Remarks) Sale 83,939 32.51 2,729,024
2020-01-02 Stephenson Brian C (See Remarks) Sale 7,164 33.86 242,573
2020-01-02 Henderson Michael Thomas (See Remarks) Sale 3,617 33.58 121,469
2020-01-02 Kumar Neil (See Remarks) Sale 36,061 33.83 1,219,943
2019-12-30 Mccormick Frank (Chairman of Oncology) Sale 17,150 36.30 622,562
2019-12-27 Mccormick Frank (Chairman of Oncology) Sale 82,850 39.65 3,285,085
2019-07-01 Kkr Genetic Disorder Gp Llc (10% Owner) Buy 2,647,100 17.00 45,000,700
2019-07-01 Stephenson Brian C (See Remark) Buy 55,500 17.00 943,500
2019-07-01 Stephenson Brian C (See Remark) Option Ex 312,946 .00 0
2019-07-01 Henderson Michael Thomas (See Remarks) Buy 7,000 17.00 119,000
2019-07-01 Henderson Michael Thomas (See Remarks) Option Ex 173,767 .00 0
2019-07-01 Turtle Cameron (See Remarks) Option Ex 12,630 .00 0
2019-07-01 Sinha Uma (Chief Scientific Officer) Buy 14,000 17.00 238,000
2019-07-01 Kumar Neil (See Remarks) Option Ex 8,952,428 .00 0
2019-07-01 Mccormick Frank (Chairman of Oncology) Option Ex 1,361,426 .00 0
2019-07-01 Scheller Richard H (See Remarks) Option Ex 163,427 .00 0
2019-07-01 Homcy Charles J (Chairman of Pharmaceuticals) Option Ex 1,361,426 .00 0
2019-06-27 Shabet Rose Sharon Buy 9,411,800 17.00 160,000,600

Insider trading activities including stock purchases, stock sales, and option exercises of BBIO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bridgebio Pharma, Inc. (symbol BBIO, CIK number 1743881) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month